Yugang Wu

663 citations
28 papers · 497 indexed · h-index 14
Topics
Immunotherapy and Immune Responses (6 papers)Cancer Immunotherapy and Biomarkers (6 papers)Immune Cell Function and Interaction (5 papers)
Partner nations
ChinaAustraliaGermany

In The Last Decade

Yugang Wu

26 papers receiving 491 citations

Peers

Yugang Wu
Comparison fields: 5 of 56
  • Oncology 286
  • Immunology 238
  • Molecular Biology 113
  • Cancer Research 85
  • Pulmonary and Respiratory Medicine 72
Replace Yoshihisa Arita with:
Yoshihisa Arita Japan
Cristina Migali Italy
Eugene Makarev United States
Emilien Loeuillard United States
Jieti Wang China
Yusaku Watanabe Japan
Alice Hervieu France
Casilda Llácer Spain
Mu Yan Cai China
Philip Hicks United States
Yugang Wu relative to Yoshihisa Arita Japan Yoshihisa Arita's profile →
Citations per field
00.5×3.0×
Yoshihisa Arita · 1×
Citations per year

Countries citing papers authored by Yugang Wu

Since Specialization
Citations

This map shows the geographic impact of Yugang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yugang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yugang Wu more than expected).

Fields of papers citing papers by Yugang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yugang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yugang Wu. The network helps show where Yugang Wu may publish in the future.

Co-authorship network of co-authors of Yugang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yugang Wu. A scholar is included among the top collaborators of Yugang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yugang Wu. Yugang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 11
3 4
4 0
5 16
6 1
7 8
8 13
9 10
10 15
11 1
12 16
13 1
14 49
15 115
16 57
17 36
18 22
19 10
20
Dendritic cells as vectors for immunotherapy of tumor and its application for gastric cancer therapy.
20

About Yugang Wu

Yugang Wu is a scholar working on Oncology, Immunology and Gastroenterology, having authored 28 papers that have together received 497 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Immunology (238 citations), Oncology (286 citations) and Cancer Research (85 citations). Yugang Wu has collaborated with scholars based in China, Australia and Germany. Frequent co-authors include Songbing He, Dechun Li, Yanyun Zhang, Min Fei, Daiwei Wan, Dingcheng Zheng, Liang Wang, Yi Zhang, Min Jin and Liang Wang. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026